Pathstone Holdings, LLC Novo Cure LTD Transaction History
Pathstone Holdings, LLC
- $22.2 Billion
- Q4 2024
A detailed history of Pathstone Holdings, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Pathstone Holdings, LLC holds 7,607 shares of NVCR stock, worth $147,043. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,607Holding current value
$147,043% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$235 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$228 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$172 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$93.1 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$53 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.03B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...